Reprosci Biosciences Private Limited, a active private limited company, was established on 29 November 2021 in Bangalore, Karnataka, India. Engaging in biotechnology within the hospital and medical care sector, it holds CIN: U85100KA2021PTC154968. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹1.42 M.
It upholds a compliant status. Its leadership includes Sejal Ullas Shah (Director), Ketul Pragneshkumar Patel (Director), Ravi Shankar Swamy (Director). Past directors included Ravi Shankar Swamy. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Nasscom Coe-Iot, Third Floor No 29/A(E) 27Th Main 7Th Cross, Sector 1, Hsr Layout, Bangalore, Karnataka, 560102.
U85100KA2021PTC154968
154968
29 November 2021
₹4.00 M
₹1.42 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Reprosci Biosciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sejal Ullas Shah | Director | 29 Nov 2021 | Current |
| Ketul Pragneshkumar Patel | Director | 02 Aug 2023 | Current |
| Ravi Shankar Swamy | Director | 24 Dec 2021 | Current |
| Mahendra Budharam Narwaria | Director | 29 Nov 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Reprosci Biosciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2022, Reprosci Biosciences had a public holding of 4.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Reprosci Biosciences has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Reprosci Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reprosci Biosciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Reprosci Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
The activity Ketul Pragneshkumar Patel was appointed as a Director was appointed as a Director on 02 Aug 2023 & has been associated with this company since 2 years 3 months . was completed.
Progress on Reprosci Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was documented.
The activity Ravi Shankar Swamy was appointed as a Director was appointed as a Director on 24 Dec 2021 & has been associated with this company since 3 years 11 months . was completed.
Sejal Ullas Shah was appointed as a Director was appointed as a Director on 29 Nov 2021 & has been associated with this company since 3 years 11 months . was recorded as a recent event.
Progress on Mahendra Budharam Narwaria was appointed as a Director was appointed as a Director on 29 Nov 2021 & has been associated with this company since 3 years 11 months . was documented.
The CIN of Reprosci Biosciences Private Limited is U85100KA2021PTC154968.
Reprosci Biosciences Private Limited is headquartered at Nasscom Coe-Iot, Third Floor No 29/A(E) 27Th Main 7Th Cross, Sector 1, Hsr Layout, Bangalore, Karnataka, 560102.
Reprosci Biosciences Private Limited was incorporated on 29 November 2021.
The current directors of Reprosci Biosciences Private Limited are
The primary industry of Reprosci Biosciences Private Limited is Hospital And Medical Care.
Reprosci Biosciences Private Limited is unlisted.
The authorized capital of Reprosci Biosciences Private Limited is ₹4.00 M, and the paid-up capital is ₹1.42 M.
The compliance status of Reprosci Biosciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX